Roni H Amiel

Fibronostics Pte Ltd. develops and commercializes non-invasive diagnostic tests. It specializes in hepatology, nephrology, and metabolic conditions. The firm's products include LiverFACT and LiverFAST. The company is headquartered in Singapore.

Fibronostics US, Inc. operates healthcare technology company, which develops algorithms to detect disease and monitor progression. The firm provides platform that develops non-invasive algorithm based diagnostics to improve treatment outcomes, facilitate screening of specific diseases and help prognosis in various chronic conditions. The company was founded in 2015 and is headquartered in Orlando, FL.

Pinscriptive, Inc. operates as a data analytics platform to identify the clinically effective specialty medications for individual patients. It delivers evidence backed and value based decision support to payers, such as health plans, PBMs, employers, and governments, physicians, specialty biopharmaceutical manufacturers, and patients seeking to make appropriate specialty drug decision. The company was founded by Mark Lelinski and Roni H. Amiel and is headquartered in San Juan Capistrano, CA.